Copertina

Weight Loss With GLP ‐1 Agonists in Nondiabetic Adults: Systematic Review and Network Meta‐Analysis

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Michael Lim, Pooja Gokhale, Akwasi Akosah, Lorenzo Villa‐Zapata
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2026
Soggetti:	Obesity
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

GLP ‐1 Receptor/Dual Agonists for Weight Loss: A Systematic Review and Network Meta‐Analysis of RCTs
di: Jirawan Vienghirun, et al.
Pubblicazione: (2026)

Weight Loss Outcomes Between GLP ‐1 Receptor Agonists and Bariatric Surgery in Adults With Obesity: A Systematic Review, Meta‐Analysis and Meta‐Regression
di: Muhammad Tahir, et al.
Pubblicazione: (2026)

GLP‐1 Receptor Agonists and Weight Loss: A Critical Review of Mechanisms
di: Giorgia Rutigliani, et al.
Pubblicazione: (2026)

Efficacy and Safety of GLP ‐1 Receptor Agonists, Dual Agonists, and Retatrutide for Weight Loss in Adults With Overweight or Obesity: A Bayesian NMA
di: Binayak Sinha, et al.
Pubblicazione: (2025)

GLP ‐1 Receptor Agonists and Psychiatric Outcomes in Adolescents: A Systematic Review and Meta‐Analysis
di: Cynthia F. X. C. A. Silva, et al.
Pubblicazione: (2026)

Musculoskeletal Outcomes of Glucagon‐Like Peptide‐1 Receptor Agonists Versus Other Antiobesity Agents in Nondiabetic Adults
di: Jie‐Syuan Wu, et al.
Pubblicazione: (2026)

Impact of GLP ‐1 Receptor Agonist Discontinuation on Liver‐Related Parameters: A Systematic Review and Meta‐Analysis
di: Matheus Souza, et al.
Pubblicazione: (2026)

One Year of Exercise After Weight Loss Increases Postprandial GLP ‐1 Secretion in Contrast to Usual Activity or GLP ‐1 Receptor Agonist Treatment
di: Joachim Holt, et al.
Pubblicazione: (2025)

Comparative Efficacy of Metabolic/Bariatric Surgery Versus GLP ‐1 Receptor Agonists: A Network Meta‐Analysis of Randomized Controlled Trials
di: Lucas Sabatella, et al.
Pubblicazione: (2025)

GLP ‐1 Receptor Agonists and Weight Loss Among Suboptimal Responders to Metabolic Bariatric Surgery: A Target Trial Emulation
di: Haisheng Wu, et al.
Pubblicazione: (2026)

RETRACTION : Effects of GLP ‐1 Receptor Agonists on Cognitive Function in Patients With Type 2 Diabetes: A Systematic Review and Meta‐Analysis Based on Randomized Controlled Trials
Pubblicazione: (2026)

Safety of GLP ‐1 and Dual GLP ‐1/ GIP Receptor Agonists in Preconception, Pregnancy, and Lactation: A Systematic Review of Maternal, Fetal, and Neonatal Outcomes
di: Lasin Ozbek, et al.
Pubblicazione: (2026)

Micronutrient and Nutritional Deficiencies Associated With GLP ‐1 Receptor Agonist Therapy: A Narrative Review
di: Jorge Urbina, et al.
Pubblicazione: (2026)

GLP‐1 Receptor Agonists and Substance Use Disorders in Older Adults With Type 2 Diabetes: A Target Trial Emulation
di: Hao Dai, et al.
Pubblicazione: (2025)

Dietary Strategies and Nutritional Management in Patients Receiving GLP ‐1 and Dual GIP / GLP ‐1 Receptor Agonists as Adjuncts to Lifestyle Interventions: A Systematic Review of Randomised Clinical Trials
di: Rayanne Santos de Paulo, et al.
Pubblicazione: (2026)

The Impact of GLP ‐1‐Based Therapies on Cardiovascular Outcomes in Type 2 Diabetes: A Comprehensive Systematic Review and Network Meta‐Analysis
di: Shih‐Ming Chuang, et al.
Pubblicazione: (2026)

Effects of Weight Loss Interventions on Gut Microbiota‐Derived Metabolites Linked to Cardiometabolic Health: A Systematic Review and Meta‐Analysis
di: Fernando Q. Iorra, et al.
Pubblicazione: (2026)

Interpreting Pregnancy Risk After GLP ‐1 Receptor Agonists Discontinuation
di: Roberta Scairati, et al.
Pubblicazione: (2026)

Efficacy and Safety of Tirzepatide on Weight Loss in Patients Without Diabetes Mellitus: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
di: Sharath Kommu, et al.
Pubblicazione: (2025)

Weekly Subcutaneous VK2735 , a GIP / GLP ‐1 Receptor Dual Agonist, for Weight Management: Phase 2, Randomized, 13‐Week VENTURE Study
di: Harold E. Bays, et al.
Pubblicazione: (2026)

Identifying Social Media‐Based Interactions That Help Adults to Adhere to Weight Loss Goals: A Systematic Review
di: Constanze Betz, et al.
Pubblicazione: (2025)

Interpregnancy Weight Gain and Risks of Perinatal Death: A Systematic Review and Meta‐Analysis
di: Yu Tang, et al.
Pubblicazione: (2025)

Efficacy of Weight‐Lowering Agents on Fat Distribution: A Systematic Review and Network Meta‐Analysis of Randomized Controlled Trials
di: Xiuqi Qiao, et al.
Pubblicazione: (2026)

Association of GLP ‐1 Receptor Agonists With Hepatic Decompensation in the All of Us Research Program
di: Inyoung Hwang, et al.
Pubblicazione: (2026)

The Association of Sarcopenic Obesity With Respiratory Function Outcomes in Adults: A Systematic Review and Meta‐Analysis
di: Tasneem Baabbad, et al.
Pubblicazione: (2026)

Pharmacotherapies for Binge Eating Disorder: Systematic Review and Network Meta‐Analysis
di: Gabriel P. A. Costa, et al.
Pubblicazione: (2025)

Association of Glucagon‐Like Peptide‐1 Receptor Agonist Use With Risk of Psychiatric Disorders: A Systematic Review and Meta‐Analysis of Randomised Controlled Trials
di: Shumeng Han, et al.
Pubblicazione: (2026)

Association of Glucagon‐Like Peptide‐1 Receptor Agonists and Suicidality: A Systematic Review
di: Hezekiah C. T. Au, et al.
Pubblicazione: (2026)

GLP‐1 Receptor Agonist Medications for Obesity and Type 2 Diabetes Treatment: A Rapid Review of Changes in Eating Behaviors and Eating Disorder Risk
di: Hiba Jebeile, et al.
Pubblicazione: (2025)

Effect of Behavioral Weight Management Interventions on Symptoms of Binge‐Eating Disorder and Bulimia Nervosa: A Systematic Review and Meta‐Analysis
di: Michael P. Berry, et al.
Pubblicazione: (2026)

Association Between Glucagon‐Like Peptide‐1 Receptor Agonists and Suicidality: A Systematic Review
di: Timothy H. Chan, et al.
Pubblicazione: (2026)

Combining GLP ‐1 Receptor Agonists and Health‐Behaviour and Lifestyle Therapy Yields Higher Adherence and Reduces Session Needs for Successful Weight Management in Adolescence: An Observational Real‐World Single‐Center Study
di: Julia Lischka, et al.
Pubblicazione: (2026)

Effect of Clinically Significant Weight Loss on Remission of Metabolic Complications: A Rapid Review and Meta‐Analysis of Comparative Controlled Studies
di: Srividya Adapa, et al.
Pubblicazione: (2026)

Exploring the Relationship Between Obesity, Weight Loss and Health‐Related Quality of Life: An Updated Systematic Review of Reviews
di: Tone Nygaard Flølo, et al.
Pubblicazione: (2025)

Weight Loss, Obesity Medication, and Risk of Obesity‐Associated Cancer: A Meta‐Analysis of Randomized Controlled Trials
di: Chengwen Li, et al.
Pubblicazione: (2025)

GLP‐1 RA Use and Weight Loss Among Patients in a Weight Navigation Program Versus Primary Care: A Matched Cohort Study
di: Dina H. Griauzde, et al.
Pubblicazione: (2026)

Effects of Moderate‐Frequency Resistance Training on Cardiometabolic Risk Factors in Adults With Overweight or Obesity: A Systematic Review and Meta‐Analysis
di: Yigao Wu, et al.
Pubblicazione: (2026)

The Effect of Behavioral Sleep Interventions on Measures of Obesity, Dietary Intake and Physical Activity in Adults With Poor Sleep Health: A Systematic Review, Meta‐Analysis and Meta‐Regression Analysis
di: Samiul A. Mostafa, et al.
Pubblicazione: (2026)

Optimizing Obesity Management With GLP‐1 Agonist Medication Through Mobile Health Technology, Nutrition Therapy, and Progressive Strength Training: A Retrospective Program Review
di: Elizabeth Sharp Edens, et al.
Pubblicazione: (2026)

Beyond GLP ‐1 Monotherapy: Novel Multi‐Agonists, Amylin Analogues, and Combination Strategies in Obesity and Type 2 Diabetes
di: Mikhail Khachaturov, et al.
Pubblicazione: (2026)